Vyome Holdings, Inc (HIND): Shareholders' Equity
$3.76M
As of 2025-12-31
$7.31M
As of 2026-06-30
-4.2%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.76M | n/m | 2026-03-18, Balance as of period end |
| 2024-12-31 | -$4.39M | n/a | 2026-03-18, Balance as of period end |
| No annual figure between 2020-12-31 and 2024-12-31. | |||
| 2020-12-31 | $4.67M | -70.6% | 2021-03-12, Balance as of period end |
| 2019-12-31 | $15.85M | +20.9% | 2021-03-12, Balance as of period end |
| 2018-12-31 | $13.11M | -62.7% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $35.11M | -45.4% | 2019-02-22, Balance as of period end |
| 2016-12-31 | $64.31M | n/m | 2018-03-05, Balance as of period end |
| 2015-12-31 | -$55.14M | n/m | 2018-03-05, Balance as of period end |
| 2014-12-31 | -$39.86M | n/a | 2017-02-23, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $3.76M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $9.83M | -16.8% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$6.30M | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $11.11M | +806.2% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $5.59M | +2.9% |
| Medicinova Inc (MNOV) | 2025-12-31 | $41.59M | -20.8% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $70.12M | -11.3% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$6.28M | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $40.92M | -32.9% |
Compare HIND, ALLR, PVCT, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗